NCT01695681

Brief Summary

The purpose of this study is to determine the prevalence of previously undiagnosed coeliac disease based on a health survey from Tromsø, Norway. Moreover, the health impact of undiagnosed coeliac disease will be examined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 28, 2012

Completed
3 days until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2015

Completed
Last Updated

March 11, 2020

Status Verified

March 1, 2020

Enrollment Period

2.5 years

First QC Date

September 26, 2012

Last Update Submit

March 9, 2020

Conditions

Keywords

Quality of lifeCeliac Disease/diet therapyCeliac Disease/diagnosisProspective Studies

Outcome Measures

Primary Outcomes (1)

  • Gastrointestinal symptoms: Gastrointestinal symptoms rating scale (GSRS)

    The Gastrointestinal symptoms rating scale (GSRS) is a disease-specific instrument with 15 items combined into five major domains: Reflux, Abdominal pain, Indigestion, Diarrhoea and Constipation. The scale assesses symptom severity using a seven-grade Likert scale, ranging from 1 (no discomfort at all) to 7 (very severe discomfort). A lower score indicates less symptoms. GSRS is obtained at first visit and at follow-up (\>one year) to evaluate change in one of the five domain scores or total score (primary outcome)

    7 days

Secondary Outcomes (3)

  • Quality of life score: Psychological General Well-Being Index (PGWBI)

    7 days

  • Self-reported change in abdominal complaints

    One year

  • Self-reported change in energy

    One year

Study Arms (1)

Dietary instruction

OTHER

Gluten-free diet

Other: Gluten-free diet

Interventions

Dietary advice by clinical dietitian

Dietary instruction

Eligibility Criteria

Age30 Years - 87 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Increased level of serological markers (Transglutaminase 2 or Deamidated Gliadin) and biopsy verified coeliac disease

You may not qualify if:

  • Previously diagnosed coeliac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital of North Norway

Tromsø, 9038, Norway

Location

Related Publications (1)

  • Kvamme JM, Sorbye S, Florholmen J, Halstensen TS. Population-based screening for celiac disease reveals that the majority of patients are undiagnosed and improve on a gluten-free diet. Sci Rep. 2022 Jul 25;12(1):12647. doi: 10.1038/s41598-022-16705-2.

MeSH Terms

Conditions

Celiac DiseaseDisease

Interventions

Diet, Gluten-Free

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Jan- M Kvamme, MD PhD

    University of Tromso

    PRINCIPAL INVESTIGATOR
  • Trond Halstensen, MD PhD

    University of Oslo

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2012

First Posted

September 28, 2012

Study Start

October 1, 2012

Primary Completion

April 15, 2015

Study Completion

April 15, 2015

Last Updated

March 11, 2020

Record last verified: 2020-03

Locations